Management of Maintenance Therapy in ALL

Presentation Description:
Maintenance therapy for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma is a major reason for pediatric oncology clinic visits, particularly in Satellite centres. This presentation reviewed multiple facets of maintenance therapy including its importance to clinical outcome, measures taken to deal with high and low blood counts and the expectations and obligations of treating teams caring for these patients who are enrolled on a clinical trial. 

Paul Gibson, MD, FRCPC
Pediatric Oncologist Children’s Hospital, London Health Sciences Centre

Jacqueline Halton, MD, FRCPC
Pediatric Hematologist/Oncologist, Division of Hematology/Oncology
Children’s Hospital of Eastern Ontario
Professor, Faculty of Medicine
University of Ottawa
Senior Medical Officer, Children’s Oncology Group Regulatory Affairs

Comments are closed.